One-year clinical outcomes among patients with metabolic syndrome and acute myocardial infarction

Korean Circulation Journal

Volumn 43, Issue 8, 2013, Pages 519-526

  Ji, Mi Seon ^a   Jeong, Myung Ho ^a,l   Ahn, Youngkeun ^a,l   Kim, Young Jo ^b   Chae, Shung Chull ^c   Hong, Taek Jong ^d   Seong, In Whan ^e   Chae, Jei Keon ^f   Kim, Chong Jin ^g   Cho, Myeong Chan ^f   Rha, Seung Woon ^h   Bae, Jang Ho ⁱ   Seung, Ki Bae ^j   Park, Seung Jung ^k  

^a Chonnam National University Medical School   (South Korea)

^b Young Nam University Hospital   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

^d Pusan National University School of Medicine   (South Korea)

^e Chungnam National University College of Medicine   (South Korea)

^f Chungbuk National University Hospital   (South Korea)

^g Kyung Hee University College of Medicine   (South Korea)

^h Korea University College of Medicine   (South Korea)

ⁱ Konyang University   (South Korea)

^j The Catholic University of Korea   (South Korea)

^k Asan Medical Center   (South Korea)

^l Chonnam National University   (South Korea)

more..

Author keywords

Low density lipoprotein cholesterol; Metabolic syndrome; Myocardial infarction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY STENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE REGISTRY; DYSLIPIDEMIA; FEMALE; HAZARD RATIO; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HOSPITAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; MULTICENTER STUDY; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK FACTOR; TARGET VESSEL REVASCULARIZATION; TREATMENT OUTCOME;

EID: 84885460063     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2013.43.8.519     Document Type: Article

References (30)

1. Skilton MR, Moulin P, Sérusclat A, Nony P, Bonnet F. A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences. Atherosclerosis 2007;190:416-22. (Pubitemid 46074033)
2. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM; San Antonio Heart Study. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003;26:3153-9. (Pubitemid 37339513)
3. Girman CJ, Rhodes T, Mercuri M, et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004;93:136-41. (Pubitemid 38058719)
4. Selcuk H, Temizhan A, Selcuk MT, et al. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction. Coron Artery Dis 2009;20:370-5.
5. Karthikeyan G, Teo KK, Islam S, et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. J Am Coll Cardiol 2009;53:244-53.
6. Sim DS, Jeong MH, Kang JC. Current management of acute myocardial infarction: experience from the Korea Acute Myocardial Infarction Registry. J Cardiol 2010;56:1-7.
7. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 2005; 112:2735-52. (Pubitemid 41532612)
8. Zeller M, Steg PG, Ravisy J, et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005;165:1192-8. (Pubitemid 40720745)
9. Lee MG, Jeong MH, Ahn Y, et al. Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction. J Korean Med Sci 2010;25:1456-61.
10. Kim JS, Lee HC, Choi BK, et al. Impact of metabolic syndrome on instent restenosis and clinical outcomes after percutaneous coronary stent implantation. Diabetes Res Clin Pract 2010;88:e38-41.
11. Hoffmann R, Stellbrink E, Schröder J, et al. Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents. Am J Cardiol 2007; 100:1347-52. (Pubitemid 47576009)
12. Rana JS, Monraats PS, Zwinderman AH, et al. Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention. Diabetes Care 2005;28:873-7. (Pubitemid 40434488)
13. Xu D, Guo Y, Wang H, et al. The angiographic and clinical outcomes after coronary stenting in patients with metabolic syndrome. Atherosclerosis 2012;221:416-21.
14. Ascaso J, Gonzalez Santos P, Hernandez Mijares A, et al. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum. Am J Cardiovasc Drugs 2007;7:39-58. (Pubitemid 46698514)
15. Fukushima Y, Hirayama S, Ueno T, et al. Small dense LDL cholesterol is a robust therapeutic marker of statin treatment in patients with acute coronary syndrome and metabolic syndrome. Clin Chim Acta 2011; 412:1423-7.
16. Koba S, Yokota Y, Hirano T, et al. Small LDL-cholesterol is superior to LDL-cholesterol for determining severe coronary atherosclerosis. J Atheroscler Thromb 2008;15:250-60.
17. Moon JY, Kwon HM, Kwon SW, et al. Lipoprotein(a) and LDL particle size are related to the severity of coronary artery disease. Cardiology 2007;108:282-9. (Pubitemid 350126472)
18. Yazdandoust S, Parizadeh SM, Moohebati M, et al. Serum small dense low-density lipoprotein concentrations are elevated in patients with significant coronary artery stenosis and are related to features of the metabolic syndrome. Lipids 2012;47:963-72.
19. Goswami B, Rajappa M, Singh B, Ray PC, Kumar S, Mallika V. Inflammation and dyslipidaemia: a possible interplay between established risk factors in North Indian males with coronary artery disease. Cardiovasc J Afr 2010;21:103-8.
20. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006;83:461S-5S. (Pubitemid 44713219)
21. Goyal SN, Bharti S, Krishnamurthy B, Agrawal Y, Ojha SK, Arya DS. Impact of metabolic syndrome on re-stenosis development: role of drug-eluting stents. Diab Vasc Dis Res 2012;9:177-88.
22. Deedwania PC, Hunninghake DB, Bays HE, et al. Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome. Am J Cardiol 2005;95:360-6. (Pubitemid 40164540)
23. Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin. Int J Cardiol 2005;104:338-45. (Pubitemid 41375594)
24. Bahadir MA Oguz A, Uzunlulu M, Bahadir O. Effects of different statin treatments on small dense low-density lipoprotein in patients with metabolic syndrome. J Atheroscler Thromb 2009;16:684-90.
25. Devaraj S, Chan E, Jialal I. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. J Clin Endocrinol Metab 2006;91:4489-96. (Pubitemid 44833428)
26. Ray KK, Cannon CP. Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology. Curr Opin Lipidol 2004; 15:637-43. (Pubitemid 39612981)
27. Filardi PP, Cecere M, Savarese G, et al. [Inflammation and lipids in the coronary pathology. Risk factors, causes or therapeutic target?]. G Ital Cardiol (Rome) 2010;11(12 Suppl 3):10S-5S.
28. Ulus T, Parspour A, Cavusoglu Y, Entok E, Uslu I, Demirustu C. Statins improve myocardial perfusion in metabolic syndrome patients who have perfusion defects on myocardial perfusion imaging and angiographically normal coronary arteries. Eur Rev Med Pharmacol Sci 2012; 16:328-34.
29. Murrow JR, Sher S, Ali S, et al. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin. J Clin Lipidol 2012;6:42-9.
30. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619.